EUVIMEDEUVIMED entdecken
Crossref

CRISPR/Cas13a combined with reverse transcription-multienzyme isothermal rapid amplification for hepatitis B virus RNA detection

Chuiyu Zhu, Junjie Li, Haibo Yu, Kexin Xu, Xiaomei He, Zhihao Liu, Juan Chen

Analytica Chimica Acta · 2025

DOI: 10.1016/j.aca.2025.344389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2025. Verfasst von Chuiyu Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis…. Hauptthemen laut MEDLINE: Hepatitis B virus, Nucleic Acid Amplification Techniques, RNA, Viral, CRISPR-Cas Systems. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Chongqing Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hepatitis B virus (HBV) infection represents a major global public health challenge. The covalently closed circular DNA (cccDNA), which serves as the key reservoir for viral persistence, currently requires invasive liver biopsy for clinical monitoring. Recent studies have identified serum HBV pregenomic RNA (pgRNA) and its splicing variants emerging as potential noninvasive and reliable biomarkers for tracking disease progression and forecasting prognosis in chronic HBV infection. Precise detection of pgRNA is therefore essential for informed clinical decision-making and optimized patient management. RESULTS: In this study, we developed a rapid, accurate, and clinically applicable method for HBV RNA detection by integrating CRISPR/Cas13a with reverse transcription-multienzyme isothermal rapid amplification (RT-MIRA). This innovative platform enabled simultaneous amplification of two pgRNA targets within a single-tube RT-MIRA reaction, allowing dual-target detection via one-step amplification. The optimized system achieved efficient isothermal amplification with a detection sensitivity of 103 copies/mL for both total and spliced pgRNA and exhibited no cross-reactivity with other common clinical viruses. Validation using both RT-qPCR and the RT-MIRA-Cas13a assay on clinical samples from 48 HBV-infected patients demonstrated a positive prediction value of 97.2 % and a negative predictive value of 100 %. These results conclusively validate the assay's reliability for clinical application in detecting and quantifying both total pgRNA and its splicing variants. SIGNIFICANCE: This study presents a rapid and user-friendly HBV RNA detection platform capable of accurately identifying both total and spliced pgRNA. The RT-MIRA-Cas13a assay demonstrates excellent clinical potential for prognosis assessment and disease monitoring in HBV infection. Its robust performance and operational simplicity suggest strong suitability for point-of-care applications, potentially transforming chronic HBV monitoring through accessible nucleic acid testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusNucleic Acid Amplification TechniquesRNA, ViralCRISPR-Cas SystemsHumansReverse TranscriptionLimit of DetectionMolecular Diagnostic Techniques

Stichwörter der Autor:innen

CRISPR/Cas13aHBV RNANucleic acid assayReverse transcription-multienzyme isothermal rapid amplificationSplicing variants

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, the Second Affiliated Hospital, Chongqing Medical University, Chongq…
  • Key Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical Laboratory Microfluidics and SPRi Engineering Research Center, Chongqing Medical Unive…

Förderung

  • Chongqing Medical University

Zitieren

APA

Zhu, C., Li, J., Yu, H., Xu, K., He, X., Liu, Z., & Chen, J. (2025). CRISPR/Cas13a combined with reverse transcription-multienzyme isothermal rapid amplification for hepatitis B virus RNA detection. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2025.344389

Vancouver

Zhu C, Li J, Yu H, Xu K, He X, Liu Z, et al. CRISPR/Cas13a combined with reverse transcription-multienzyme isothermal rapid amplification for hepatitis B virus RNA detection. Analytica Chimica Acta. 2025. doi:10.1016/j.aca.2025.344389

BibTeX
@article{Zhu2025,
  author = {Zhu, Chuiyu and Li, Junjie and Yu, Haibo and Xu, Kexin and He, Xiaomei and Liu, Zhihao and Chen, Juan},
  title = {CRISPR/Cas13a combined with reverse transcription-multienzyme isothermal rapid amplification for hepatitis B virus RNA detection},
  journal = {Analytica Chimica Acta},
  year = {2025},
  doi = {10.1016/j.aca.2025.344389}
}
Kostenlos starten →